Free Trial
NASDAQ:AMED

Amedisys Q3 2023 Earnings Report

Amedisys logo
$96.25 +0.25 (+0.26%)
Closing price 05/5/2025 04:00 PM Eastern
Extended Trading
$96.60 +0.34 (+0.36%)
As of 04:41 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amedisys EPS Results

Actual EPS
$0.98
Consensus EPS
$1.08
Beat/Miss
Missed by -$0.10
One Year Ago EPS
$1.15

Amedisys Revenue Results

Actual Revenue
$556.24 million
Expected Revenue
$560.23 million
Beat/Miss
Missed by -$3.99 million
YoY Revenue Growth
-0.30%

Amedisys Announcement Details

Quarter
Q3 2023
Time
Q3 2023 Earnings Release
Conference Call Date
Tuesday, October 24, 2023
Conference Call Time
4:00PM ET

Upcoming Earnings

Amedisys' Q2 2025 earnings is scheduled for Wednesday, July 23, 2025, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Amedisys Earnings Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
FY2025 EPS Estimates for Amedisys Increased by William Blair
Equities Analysts Offer Predictions for Amedisys Q2 Earnings
See More Amedisys Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Amedisys? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amedisys and other key companies, straight to your email.

About Amedisys

Amedisys (NASDAQ:AMED), together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

View Amedisys Profile

More Earnings Resources from MarketBeat